Pathalys Pharma
PrivateLast Round
Series B
Aug 20, 2024
Est. Valuation
$295M
Total Funding Raised
$255M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pathalys Pharma is a biopharmaceutical company that develops advanced therapeutics to address unmet needs in the management of end-stage kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pathalys Pharma Comparables
Compare Pathalys Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kissei Pharmaceutical | 79% | |
| Amgen | 77% | |
| Eisai | 76% | |
Pathalys Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 20, 2024 | ||||
| Early Funding | Jan 18, 2023 | ||||
| Seed | Mar 1, 2022 |
Pathalys Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Post Investment Corporation | Series B |
| TCG Crossover | Series B |
| KB Investment | Series B |
| KB Investment | Series B |
| OrbiMed | Early Funding |
| Japan Post Bank Asset Management Co., Ltd. | Series B |
| The Carlyle Group | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 424% MoM, from 283 to 1.5K.
- Aug 20, 2024
$105M round led by TCG Crossover.
Pathalys Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pathalys Pharma's valuation, stock price, and market status.